Key facts
- This page summarizes Brian Keith Pilcher's Form 3 filing for Conexeu Sciences Inc..
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 May 2026, 18:47.
Brian Keith Pilcher - 11 May 2026 Form 3 Insider Report for Conexeu Sciences Inc.
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- CNXU on Nasdaq
- Reported as of
- 11 May 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Brian Pilcher
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Brian Keith Pilcher filed Form 3 for Conexeu Sciences Inc. on 11 May 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002127828
Primary reporting owner
Pilcher Brian Keith
- Relationship
- Chief Medical Officer
- Address
- 50 WEST LIBERTY STREET, SUITE 880, RENO
- Signature
- /s/ Brian Pilcher
- Signature date
- 11 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87,861
- Date
- 11 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No ticker
holding
Derivative
Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 11 May 2026
- Ownership
- By Critical Mass Scientific Strategy Consultants, LLC
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.4000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On April 1, 2025, the Company granted 100,000 stock options with an exercise price of $0.40 to Critical Mass Scientific Strategy Consultants, LLC, over which Mr. Pilcher has sole voting and dispositive power. The options have vested and will expire and terminate at 5:00 p.m. (Pacific Time) on the date that is 24 months from the date of grant of the options.